Autolus Therapeutics Plc (AUTL)
2.345
-0.06
(-2.70%)
USD |
NASDAQ |
Aug 24, 16:00
2.34
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics EPS Diluted (Quarterly) : -0.1472 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1472 |
| March 31, 2026 | -0.2686 |
| December 31, 2025 | -0.3389 |
| September 30, 2025 | -0.2954 |
| June 30, 2025 | -0.1823 |
| March 31, 2025 | -0.2636 |
| December 31, 2024 | -0.1028 |
| September 30, 2024 | -0.3085 |
| June 30, 2024 | -0.219 |
| March 31, 2024 | -0.2372 |
| December 31, 2023 | -0.4434 |
| September 30, 2023 | -0.262 |
| June 30, 2023 | -0.2629 |
| March 31, 2023 | -0.2311 |
| December 31, 2022 | -0.1569 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.4687 |
| June 30, 2022 | -0.4625 |
| March 31, 2022 | -0.4077 |
| December 31, 2021 | -0.4583 |
| September 30, 2021 | -0.4663 |
| June 30, 2021 | -0.4683 |
| March 31, 2021 | -0.5327 |
| December 31, 2020 | -0.8188 |
| September 30, 2020 | -0.7163 |
| June 30, 2020 | -0.6158 |
| March 31, 2020 | -0.5991 |
| December 31, 2019 | -0.9102 |
| September 30, 2019 | -0.6122 |
| June 30, 2019 | -0.653 |
| March 31, 2019 | -0.6886 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | -0.7224 |
| Biodexa Pharmaceuticals Plc | -- |
| argenx SE | -- |
| Mereo BioPharma Group Plc | -0.0437 |
| Evaxion AS | -0.4464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.18M |
| Revenue (Quarterly) | 45.77M |
| Total Expenses (Quarterly) | 84.95M |
| Enterprise Value | 806.14M |
| Gross Profit Margin (Quarterly) | 55.20% |
| Profit Margin (Quarterly) | -85.60% |
| Earnings Yield | -44.78% |
| Normalized Earnings Yield | -44.74 |